Page 24 - PowerPoint Presentation
P. 24
Use of Funds – Development of First Drug Program
Direct Expenses (Hem A+B Programs) Indirect Expenses
R&D Facilities
UPenn SRA $ 318,000 Rent+Taxes $ 100,000
Outsource Molecular Genetics $ 25,000 Supplies $ 10,000
Supplies $ 35,000 $ 110,000
Travel $ 10,000
$ 388,000 Employees
Payroll $ 1,080,000
CMC Expenses $ 432,000
Materials $ 50,000 $ 1,512,000
Lyophilizer Move/Install $ 25,000
Lyophilizer Lease $ 9,600
Request: $3.0M Consulting (H&L) $ 75,000
$
Consulting (Insperity)
350,000
$ 509,600
Preclinical
Series A to follow closely Mouse studies $ 150,000
Rabbit studies/Lg Animal
25,000
$
Travel $ 10,000
$ 185,000
Clinical
Consulting $ 50,000
Travel $ 25,000
$ 75,000
IP/Legal
Patents $ 200,000
Costs $ 75,000
$ 275,000
TOTAL (Direct Expenses) $ 1,432,600
TOTAL (Indirect Expenses) $ 1,622,000
TOTAL FUND REQUEST: $ 3,054,600
Note: Additional funding may be required to IND approval
1. Outsource Molecular Genetics: $75,000
C O N F I D E N T I A L © 2 0 2 3 Z E A B I O S C I E N C E S C O R P 2. Rabit studies/Lg Animal: $575,000
3. Clinical Travel: $10,000
